Abstract

Biological cells are complex living machines that have garnered significant attention for their potential to serve as a new generation of therapeutic and delivery agents. Because of their secretion, differentiation, and homing activities, therapeutic cells have tremendous potential to treat or even cure various diseases and injuries that have defied conventional therapeutic strategies. Therapeutic cells can be systemically or locally transplanted. In addition, with their ability to express receptors that bind specific tissue markers, cells are being studied as nano- or microsized drug carriers capable of targeted transport. Depending on the therapeutic targets, these cells may be clustered to promote intercellular adhesion. Despite some impressive results with preclinical studies, there remain several obstacles to their broader development, such as a limited ability to control their transport, engraftment, secretion and to track them in vivo. Additionally, creating a particular spatial organization of therapeutic cells remains difficult. Efforts have recently emerged to resolve these challenges by engineering cell surfaces with a myriad of bioactive molecules, nanoparticles, and microparticles that, in turn, improve the therapeutic efficacy of cells. This review article assesses the various technologies developed to engineer the cell surfaces. The review ends with future considerations that should be taken into account to further advance the quality of cell surface engineering.

Original languageEnglish (US)
Pages (from-to)1664-1690
Number of pages27
JournalChemical reviews
Volume118
Issue number4
DOIs
StatePublished - Feb 28 2018

Fingerprint

Cell engineering
Drug Carriers
Adhesion
Tissue
Nanoparticles
Engineers
Molecules

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Engineering the Surface of Therapeutic "living" Cells. / Park, Jooyeon; Andrade, Brenda; Seo, Yongbeom; Kim, Myung Joo; Zimmerman, Steven C; Kong, Hyun Joon.

In: Chemical reviews, Vol. 118, No. 4, 28.02.2018, p. 1664-1690.

Research output: Contribution to journalReview article

Park, Jooyeon ; Andrade, Brenda ; Seo, Yongbeom ; Kim, Myung Joo ; Zimmerman, Steven C ; Kong, Hyun Joon. / Engineering the Surface of Therapeutic "living" Cells. In: Chemical reviews. 2018 ; Vol. 118, No. 4. pp. 1664-1690.
@article{b7b2d3538e7d4710b26fb552f2be61dd,
title = "Engineering the Surface of Therapeutic {"}living{"} Cells",
abstract = "Biological cells are complex living machines that have garnered significant attention for their potential to serve as a new generation of therapeutic and delivery agents. Because of their secretion, differentiation, and homing activities, therapeutic cells have tremendous potential to treat or even cure various diseases and injuries that have defied conventional therapeutic strategies. Therapeutic cells can be systemically or locally transplanted. In addition, with their ability to express receptors that bind specific tissue markers, cells are being studied as nano- or microsized drug carriers capable of targeted transport. Depending on the therapeutic targets, these cells may be clustered to promote intercellular adhesion. Despite some impressive results with preclinical studies, there remain several obstacles to their broader development, such as a limited ability to control their transport, engraftment, secretion and to track them in vivo. Additionally, creating a particular spatial organization of therapeutic cells remains difficult. Efforts have recently emerged to resolve these challenges by engineering cell surfaces with a myriad of bioactive molecules, nanoparticles, and microparticles that, in turn, improve the therapeutic efficacy of cells. This review article assesses the various technologies developed to engineer the cell surfaces. The review ends with future considerations that should be taken into account to further advance the quality of cell surface engineering.",
author = "Jooyeon Park and Brenda Andrade and Yongbeom Seo and Kim, {Myung Joo} and Zimmerman, {Steven C} and Kong, {Hyun Joon}",
year = "2018",
month = "2",
day = "28",
doi = "10.1021/acs.chemrev.7b00157",
language = "English (US)",
volume = "118",
pages = "1664--1690",
journal = "Chemical Reviews",
issn = "0009-2665",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Engineering the Surface of Therapeutic "living" Cells

AU - Park, Jooyeon

AU - Andrade, Brenda

AU - Seo, Yongbeom

AU - Kim, Myung Joo

AU - Zimmerman, Steven C

AU - Kong, Hyun Joon

PY - 2018/2/28

Y1 - 2018/2/28

N2 - Biological cells are complex living machines that have garnered significant attention for their potential to serve as a new generation of therapeutic and delivery agents. Because of their secretion, differentiation, and homing activities, therapeutic cells have tremendous potential to treat or even cure various diseases and injuries that have defied conventional therapeutic strategies. Therapeutic cells can be systemically or locally transplanted. In addition, with their ability to express receptors that bind specific tissue markers, cells are being studied as nano- or microsized drug carriers capable of targeted transport. Depending on the therapeutic targets, these cells may be clustered to promote intercellular adhesion. Despite some impressive results with preclinical studies, there remain several obstacles to their broader development, such as a limited ability to control their transport, engraftment, secretion and to track them in vivo. Additionally, creating a particular spatial organization of therapeutic cells remains difficult. Efforts have recently emerged to resolve these challenges by engineering cell surfaces with a myriad of bioactive molecules, nanoparticles, and microparticles that, in turn, improve the therapeutic efficacy of cells. This review article assesses the various technologies developed to engineer the cell surfaces. The review ends with future considerations that should be taken into account to further advance the quality of cell surface engineering.

AB - Biological cells are complex living machines that have garnered significant attention for their potential to serve as a new generation of therapeutic and delivery agents. Because of their secretion, differentiation, and homing activities, therapeutic cells have tremendous potential to treat or even cure various diseases and injuries that have defied conventional therapeutic strategies. Therapeutic cells can be systemically or locally transplanted. In addition, with their ability to express receptors that bind specific tissue markers, cells are being studied as nano- or microsized drug carriers capable of targeted transport. Depending on the therapeutic targets, these cells may be clustered to promote intercellular adhesion. Despite some impressive results with preclinical studies, there remain several obstacles to their broader development, such as a limited ability to control their transport, engraftment, secretion and to track them in vivo. Additionally, creating a particular spatial organization of therapeutic cells remains difficult. Efforts have recently emerged to resolve these challenges by engineering cell surfaces with a myriad of bioactive molecules, nanoparticles, and microparticles that, in turn, improve the therapeutic efficacy of cells. This review article assesses the various technologies developed to engineer the cell surfaces. The review ends with future considerations that should be taken into account to further advance the quality of cell surface engineering.

UR - http://www.scopus.com/inward/record.url?scp=85042729204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042729204&partnerID=8YFLogxK

U2 - 10.1021/acs.chemrev.7b00157

DO - 10.1021/acs.chemrev.7b00157

M3 - Review article

C2 - 29336552

AN - SCOPUS:85042729204

VL - 118

SP - 1664

EP - 1690

JO - Chemical Reviews

JF - Chemical Reviews

SN - 0009-2665

IS - 4

ER -